Table 2 Comparison of clinical outcomes in COVID-19 patients with diabetes mellitus vs. without diabetes mellitus.
From: The outcomes of patients with diabetes mellitus in The Philippine CORONA Study
Outcomes | Diabetic | Non-diabetic | p-value |
|---|---|---|---|
(n = 2191) | (n = 8690) | ||
Final outcome | |||
In-hospital mortality, n (%) | 579 (26.43%) | 1123 (12.92%) | < 0.001 |
Discharged, n (%) | 1612 (73.57%) | 7567 (87.08%) | < 0.001 |
Time to in-hospital mortality in days, median (IQR) | 16 (14) | 14 (13) | < 0.001 |
Respiratory failure, n (%) | 656 (29.94%) | 952 (10.96%) | < 0.001 |
Duration of IMV in days, median (IQR) | 14 (12) | 12 (11) | 0.002 |
IMV dependence < 14 days, n (%) | 314 (47.87%) | 530 (55.79%) | 0.002 |
IMV dependence ≥ 14 days, n (%) | 342 (52.13%) | 420 (44.21%) | |
COVID-19 severity at nadir | |||
Mild/moderate, n (%) | 923 (42.57%) | 5767 (67.19%) | < 0.001 |
Severe/critical, n (%) | 1245 (57.43%) | 2816 (32.81%) | |
Admitted to ICU, n (%) | 739 (33.73%) | 1001 (11.52%) | < 0.001 |
Length of ICU stay in days, median (IQR) | 15 (11) | 14 (12) | 0.596 |
ICU stay ≤ 7 days, n (%) | 119 (16.10%) | 153 (15.28%) | 0.642 |
ICU stay > 7 days, n (%) | 620 (83.90%) | 848 (84.72%) | |
Length of hospital staya in days, median (IQR) | 14 (10) | 13 (9) | < 0.001 |
Hospital stay ≤ 14 days, n (%) | 1209 (55.18%) | 5368 (61.77%) | < 0.001 |
Hospital stay > 14 days, n (%) | 982 (44.82%) | 3322 (38.23%) | |
Neurologic outcome on dischargeb | |||
Full/partial neurologic recovery, n (%) | 368 (76.67%) | 1271 (89.19%) | < 0.001 |
No recovery, n (%) | 112 (23.33%) | 154 (10.81%) | |
